多模态数据整合机器学习预测透明细胞肾癌转移风险:回顾性多中心研究
本研究基于三家医院251例病理确诊ccRCC患者的临床、CT及超声数据,构建临床、影像组学及联合模型预测淋巴结转移。联合模型在训练集、内部测试集、外部测试集的AUC分别为0.924、0.877、0.849,均优于单一模型。DCA显示联合模型具有更优的临床预测效用。
要点
- 联合临床+CT/超声影像组学模型预测ccRCC淋巴结转移优于单一模型。
- 外部测试集联合模型AUC为0.849,提示一定泛化能力。
- 决策曲线分析支持联合模型的临床净获益。
核心结论
- 联合模型在预测ccRCC患者淋巴结转移方面优于临床模型和影像组学模型。
研究设计与样本
- 回顾性多中心研究,纳入2013年1月至2023年1月三家三级医院病理确诊ccRCC患者共251例。
- 训练集为山东大学齐鲁医院(济南)166例(50例发生转移),内部测试集为山东大学齐鲁医院(青岛)37例(15例转移),外部测试集为常州市第二人民医院48例(13例转移)。
- 基于临床及影像数据(CT和超声)构建临床模型、影像组学模型及联合模型。
- 以AUC、准确率、敏感度、特异度、阴性预测值、阳性预测值及DCA曲线评估模型性能。
诊断标准与关键数值
- 训练集中联合模型预测淋巴结转移AUC为0.924,临床模型AUC为0.845,影像组学模型AUC为0.870。
- 内部测试集中联合模型AUC为0.877,临床模型AUC为0.726,影像组学模型AUC为0.836。
- 外部测试集中联合模型AUC为0.849,临床模型AUC为0.708,影像组学模型AUC为0.804。
- DCA曲线显示联合模型在预测ccRCC患者淋巴结转移风险方面较临床模型或影像组学模型有显著预测概率。
临床应用与阅片要点
- 可考虑整合临床信息与CT/超声影像组学特征来辅助评估ccRCC淋巴结转移风险。
- 联合模型在外部测试集中仍保持较高AUC,提示其可能适用于不同区域人群。
局限性
- 回顾性研究设计。
- 样本量有限(共251例),外部测试集仅48例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To develop and validate a predictive combined model for metastasis in patients with clear cell renal cell carcinoma (ccRCC) by integrating multimodal data.
MATERIALS AND METHODS: In this retrospective study, the clinical and imaging data (CT and ultrasound) of patients with ccRCC confirmed by pathology from three tertiary hospitals in different regions were collected from January 2013 to January 2023. We developed three models, including a clinical model, a radiomics model, and a combined model. The performance of the model was determined based on its discriminative power and clinical utility. The evaluation indicators included area under the receiver operating characteristic curve (AUC) value, accuracy, sensitivity, specificity, negative predictive value, positive predictive value and decision curve analysis (DCA) curve.
RESULTS: A total of 251 patients were evaluated. Patients (n = 166) from Shandong University Qilu Hospital (Jinan) were divided into the training cohort, of which 50 patients developed metastases; patients (n = 37) from Shandong University Qilu Hospital (Qingdao) were used as internal testing, of which 15 patients developed metastases; patients (n = 48) from Changzhou Second People's Hospital were used as external testing, of which 13 patients developed metastases. In the training set, the combined model showed the highest performance (AUC, 0.924) in predicting lymph node metastasis (LNM), while the clinical and radiomics models both had AUCs of 0.845 and 0.870, respectively. In the internal testing, the combined model had the highest performance (AUC, 0.877) for predicting LNM, while the AUCs of the clinical and radiomics models were 0.726 and 0.836, respectively. In the external testing, the combined model had the highest performance (AUC, 0.849) for predicting LNM, while the AUCs of the clinical and radiomics models were 0.708 and 0.804, respectively. The DCA curve showed that the combined model had a significant prediction probability in predicting the risk of LNM in ccRCC patients compared with the clinical model or the radiomics model.
CONCLUSION: The combined model was superior to the clinical and radiomics models in predicting LNM in ccRCC patients.
引用
- Yang Y, Wang J, Ren Q, et al. Multimodal data integration using machine learning to predict the risk of clear cell renal cancer metastasis: a retrospective multicentre study. Abdom Radiol (NY). 2024. PMID: 38879708. doi:10.1007/s00261-024-04418-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。